Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.060
+0.020 (1.92%)
Nov 21, 2024, 4:00 PM EST - Market closed

Ovid Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
75228131219147198
Upgrade
Market Cap Growth
-69.11%73.64%-40.04%49.16%-26.16%232.60%
Upgrade
Enterprise Value
2815791760161
Upgrade
Last Close Price
1.063.221.863.212.314.15
Upgrade
PE Ratio
---1.82--
Upgrade
PS Ratio
118.85581.0487.221.0511.61-
Upgrade
PB Ratio
0.992.590.991.223.362.83
Upgrade
P/TBV Ratio
1.102.600.991.223.382.85
Upgrade
P/FCF Ratio
---1.85--
Upgrade
P/OCF Ratio
---1.84--
Upgrade
EV/Sales Ratio
43.74400.366.290.084.73-
Upgrade
EV/EBITDA Ratio
---0.13--
Upgrade
EV/EBIT Ratio
---0.14--
Upgrade
EV/FCF Ratio
---0.14--
Upgrade
Debt / Equity Ratio
0.200.180.13---
Upgrade
Asset Turnover
0.010.000.011.540.16-
Upgrade
Quick Ratio
5.399.2218.4512.693.277.39
Upgrade
Current Ratio
5.669.5518.7912.873.397.58
Upgrade
Return on Equity (ROE)
-36.60%-47.57%-34.72%109.98%-142.60%-111.11%
Upgrade
Return on Assets (ROA)
-36.04%-24.76%-19.85%57.40%-64.93%-59.74%
Upgrade
Return on Capital (ROIC)
-39.27%-29.33%-21.13%69.51%-89.56%-70.53%
Upgrade
Earnings Yield
-43.18%-23.00%-41.33%56.20%-55.30%-30.47%
Upgrade
FCF Yield
-76.95%-20.13%-43.07%54.18%-35.29%-25.78%
Upgrade
Buyback Yield / Dilution
-0.42%-0.22%-3.46%-16.45%-49.04%-59.22%
Upgrade
Total Shareholder Return
-0.42%-0.22%-3.46%-16.45%-49.04%-59.22%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.